Sakar Healthcare Ltd

Sakar Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sakar Healthcare Ltd

₹ 348 -0.68%
03 May - close price
Company website NSE : SAKAR
About

Sakar Healthcare Ltd is engaged in manufacturing of Pharmaceutical formulations in the form of liquid injectables, tablets/ capsules, oral liquid syrups, dry powder injectables and syrups.[1]
The company also operates as a contract development and manufacturing organization (CDMO) for various leading pharmaceutical companies.[2]

Key Points

Product Portfolio
The company manufactures various pharma products like injectables, tablets/ capsules, oral liquid syrups, dry power injections, syrups, etc. for various therapeutic segments like antibiotics, anti-cold drugs, anti-malarial, multi-vitamins, amino acids, etc.[1]
It is involved in manufacturing and marketing of medicines with a product portfolio of ~150 formulations in more than 23 therapeutic areas.[2]

Website NSE
  • Market Cap ₹ 758 Cr.
  • Current Price ₹ 348
  • High / Low ₹ 479 / 215
  • Stock P/E 60.7
  • Book Value ₹ 109
  • Dividend Yield 0.00 %
  • ROCE 8.97 %
  • ROE 8.55 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Stock is trading at 3.20 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 11.0% over last 3 years.
  • Company might be capitalizing the interest cost
  • Debtor days have increased from 49.5 to 60.4 days.
  • Promoter holding has decreased over last 3 years: -20.9%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
26.79 21.68 30.26 31.64 29.74 36.59 28.53 30.71 33.47 40.65 38.99 34.08 37.23
22.93 14.62 23.77 24.55 23.09 27.48 20.57 22.12 24.67 32.87 29.96 24.72 28.22
Operating Profit 3.86 7.06 6.49 7.09 6.65 9.11 7.96 8.59 8.80 7.78 9.03 9.36 9.01
OPM % 14.41% 32.56% 21.45% 22.41% 22.36% 24.90% 27.90% 27.97% 26.29% 19.14% 23.16% 27.46% 24.20%
0.27 0.41 0.27 0.75 0.27 0.88 0.41 0.60 1.85 1.81 1.52 0.66 0.23
Interest 0.80 0.43 0.49 0.79 0.94 0.68 0.86 0.99 1.94 2.15 2.08 1.65 1.79
Depreciation 1.08 4.82 2.18 1.68 2.62 3.19 3.57 3.77 4.10 3.55 4.52 4.22 4.44
Profit before tax 2.25 2.22 4.09 5.37 3.36 6.12 3.94 4.43 4.61 3.89 3.95 4.15 3.01
Tax % 20.44% 22.52% 10.51% 54.19% 96.43% -46.24% 26.90% 56.21% 13.02% -0.77% 28.10% 12.53% 30.90%
1.80 1.73 3.65 2.46 0.11 8.95 2.88 1.94 4.01 3.92 2.84 3.64 2.07
EPS in Rs 1.20 1.11 2.13 1.44 0.06 5.23 1.68 1.04 2.15 2.06 1.49 1.70 0.95
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
83 95 128 133 151
63 72 99 100 116
Operating Profit 20 23 29 33 35
OPM % 24% 24% 23% 25% 23%
2 1 2 4 4
Interest 2 2 3 6 8
Depreciation 7 8 10 15 17
Profit before tax 12 13 19 17 15
Tax % 21% 19% 20% 24%
10 11 15 13 12
EPS in Rs 6.43 6.84 8.90 6.70 6.20
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 17%
TTM: 17%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 10%
TTM: -30%
Stock Price CAGR
10 Years: %
5 Years: 41%
3 Years: 33%
1 Year: 61%
Return on Equity
10 Years: %
5 Years: %
3 Years: 11%
Last Year: 9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 15 16 17 19 21
Reserves 66 83 110 154 216
17 43 93 119 68
17 37 47 44 52
Total Liabilities 115 178 268 336 357
66 69 205 267 275
CWIP 13 49 1 6 8
Investments 0 0 7 3 0
36 60 55 60 75
Total Assets 115 178 268 336 357

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023
19 15 36 33
-22 -47 -90 -74
3 32 55 41
Net Cash Flow -0 -0 -0 0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 36 48 40 60
Inventory Days 93 112 69 76
Days Payable 46 141 149 129
Cash Conversion Cycle 83 19 -39 7
Working Capital Days 41 8 2 30
ROCE % 13% 12% 9%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
67.54% 67.54% 67.54% 67.54% 67.54% 62.10% 62.10% 60.72% 60.72% 54.15% 53.15% 53.15%
0.00% 0.00% 0.00% 0.00% 0.00% 16.12% 16.12% 15.74% 15.74% 14.03% 13.76% 13.52%
8.76% 8.76% 8.76% 8.76% 8.76% 0.55% 0.33% 0.00% 0.00% 10.82% 10.62% 10.62%
23.70% 23.70% 23.70% 23.70% 23.70% 21.24% 21.45% 23.54% 23.54% 21.00% 22.47% 22.71%
No. of Shareholders 4,6046,4816,5426,7026,0915,6786,2106,3226,0567,2997,0017,386

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings